创金合信基金毛丁丁：人工智能刺激深度研发 AI医疗投资机会巨大

Core Viewpoint - The rapid adoption of artificial intelligence (AI) in the healthcare and pharmaceutical sectors is expected to address significant pain points, leading to enhanced efficiency and productivity across the entire medical value chain, thus creating substantial investment opportunities in AI healthcare and pharmaceuticals [1] Group 1: Industry Pain Points - There are considerable challenges in various aspects of the global healthcare and pharmaceutical industry, including the deep exploration and efficient application of life gene information, the screening and combination of drug targets, the urgent need to improve diagnostic and treatment efficiency, and the significant information asymmetry between doctors and patients [1] Group 2: Investment Opportunities - The application of AI technology is anticipated to play a significant role in alleviating the aforementioned pain points, which will liberate productivity across the pharmaceutical value chain and foster a vast space for imagination and investment opportunities in AI healthcare and pharmaceuticals [1]